A core outcome set for studies evaluating interventions to prevent and/or treat delirium for adults requiring an acute care hospital admission: an international key stakeholder informed consensus study

Abstract

Background Trials of interventions to prevent or treat delirium in adults in an acute hospital setting report heterogeneous outcomes. Our objective was to develop international consensus among key stakeholders for a core outcome set (COS) for future trials of interventions to prevent and/or treat delirium in adults with an acute care hospital admission and not admitted to an intensive care unit. Methods A rigorous COS development process was used including a systematic review, qualitative interviews, modified Delphi consensus process, and in-person consensus using nominal group technique (registration http://www.comet- initiative.org/studies/details/796). Participants in qualitative interviews were delirium survivors or family members. Participants in consensus methods comprised international representatives from three stakeholder groups: researchers, clinicians, and delirium survivors and family members. Results Item generation identified 8 delirium-specific outcomes and 71 other outcomes from 183 studies, and 30 outcomes from 18 qualitative interviews, including 2 that were not extracted from the systematic review. De-duplication of outcomes and formal consensus processes involving 110 experts including researchers (N = 32), clinicians (N = 63), and delirium survivors and family members (N = 15) resulted in a COS comprising 6 outcomes: delirium occurrence and reoccurrence, delirium severity, delirium duration, cognition, emotional distress, and health-related quality of life. Study limitations included exclusion of non-English studies and stakeholders and small representation of delirium survivors/family at the in-person consensus meeting. Conclusions This COS, endorsed by the American and Australian Delirium Societies and European Delirium Association, is recommended for future clinical trials evaluating delirium prevention or treatment interventions in adults presenting to an acute care hospital and not admitted to an intensive care unit.

Risk factors for pulmonary complications after colorectal surgery: a Japanese multicenter study

“…Pneumonia and surgical site infection at the sternum were the most common. Delirium is usually reversible, but is associated with longer hospitalization, worse prognosis, and increased mortality [17]. PC and delirium may be caused by decreased activities of daily living due to trunk suppression caused by delirium or, conversely, by a cytokine upsurge caused by PC, which may impair optimal oxygenation of the brain.…”

Postoperative delirium in older patients with cancer: the role of psychological distress and social support

“…Relief of patient (and family) distress motivates clinicians to intervene [21]; yet, these outcomes have been rarely measured in delirium intervention studies. This evidence-practice gap may soon be rectified by inclusion of 'emotional distress' in a new core outcome set for studies of interventions to prevent and/or treat delirium for adults in acute care [22]. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.…”

Advancing specificity in delirium: The delirium subtyping initiative

“…Thorough guidelines, statements, and core outcome sets for delirium have previously been produced using consensus methods 13 19–30 . For example, the Network for Investigation of Delirium: Unifying Scientists (NIDUS) 2020 Scientific Think Tank listed identifying etiologic subtypes of delirium as a priority 31 .…”

“…Thorough guidelines, statements, and core outcome sets for delirium have previously been produced using consensus methods. 13 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 For example, the Network for Investigation of Delirium: Unifying Scientists (NIDUS) 2020 Scientific Think Tank listed identifying etiologic subtypes of delirium as a priority. 31 The think tank suggested that future studies should use standardized approaches to identify contributors to delirium, to incorporate biomarkers, and to use subtyping to guide targeted treatments.…”